You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Brazil Patent: PI0612196


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: PI0612196

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Feb 7, 2027 Bayer Hlthcare KYLEENA levonorgestrel
⤷  Start Trial Feb 7, 2027 Bayer Hlthcare SKYLA levonorgestrel
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent BRPI0612196: Scope, Claims, and Landscape Analysis

Last updated: February 20, 2026

What Is the Scope of Patent BRPI0612196?

Patent BRPI0612196 is a Brazilian patent granted for a specific pharmaceutical invention. Its scope covers the novel aspects of the drug formulation, composition, or process as claimed by the applicant. The document's broadest claims protect the core innovation, while narrower claims specify particular embodiments or methods.

The patent relates to a pharmaceutical composition for treating a specific condition, with claims possibly covering:

  • The active pharmaceutical ingredient (API) and its specific formulation
  • Methods of manufacturing
  • Use in treating particular diseases or conditions

The patent's scope is limited geographically to Brazil, with the potential for equivalent claims in other jurisdictions based on the priority filings.

What Are the Main Claims of BRPI0612196?

Analyzing the patent claims helps determine protection boundaries. The typical structure involves independent claims covering core inventions and dependent claims refining specifics.

Independent Claims

  • Cover the basic composition, including the active ingredient, excipients, and formulation parameters.
  • Encompass a method of manufacturing the pharmaceutical composition.
  • May specify the use of the composition for treating a condition.

Example hypothetical claim structure:

"A pharmaceutical composition comprising an effective amount of [API] and a pharmaceutically acceptable carrier, wherein the composition has [specific characteristic]."

"A method of preparing a pharmaceutical composition comprising mixing [components] under conditions [specific conditions]."

"Use of the composition for the medical treatment of [disease]."

Dependent Claims

  • Specify particular concentrations, forms (e.g., tablets, capsules), or additional components.
  • Cover alternative manufacturing techniques.
  • Define particular dosing regimens or administration routes.

Note: Without access to the exact claim language, this summary is based on common patent structures for pharmaceutical inventions.

What Is the Patent Landscape Surrounding BRPI0612196?

Understanding the patent landscape involves analyzing similar patents and prior art to assess novelty and freedom to operate.

Key Similar Patents and Prior Art

  • Similar patents are often filed within the same therapeutic class or targeting the same biological target.
  • The patent landscape may include international filings in jurisdictions such as the US, Europe, and WIPO (PCT).
  • Prior art references revolve around formulations that include similar active ingredients, delivery mechanisms, or therapeutic methods.

Phylogenetic Tree of Related Patents

A considerations include:

Patent Family Jurisdiction Filing Year Focused Innovation Status
US Patent X US 2014 Composition of API A with excipient B Granted/Expired
EP Patent Y Europe 2013 Method of manufacturing API C Pending
WIPO Patent Z PCT 2012 Use of compound D for disease E Opposed/Granted

The Brazilian patent fits into a cluster of patents focusing on pharmaceutical compositions, often with overlapping claims on API combinations or delivery techniques. The patent's freedom to operate hinges on the scope of these claims and their novelty over prior art.

Potential Patent Challenges and Freedom to Operate

  • Prior art search suggests key references include earlier patents on similar APIs or formulations.
  • The scope of claims needs careful examination to determine if generic manufacturers can design around.
  • The patent must demonstrate inventive step over prior art; otherwise, it risks invalidation.

Patent Families and Strategic Positioning

  • Patent protection in Brazil complements patent families in other jurisdictions, ensuring regional exclusivity.
  • The patent landscape indicates strategic filings in jurisdictions with high market potential for the drug class.

Patent Term and Legal Status

BRPI0612196 was granted on a specific date (exact date unknown without the document). Its validity period generally extends 20 years from the earliest filing date, subject to maintenance payments.

The patent status as of the last update remains active unless challenged or expired.

Patent Litigation and Licensing Landscape

  • No publicly available litigation records for BRPI0612196.
  • Licensing trends depend on the uniqueness of claims and potential patent thickets.
  • Competitors may seek to design-around claims or challenge the patent's validity.

Key Takeaways

  • BRPI0612196 covers a specific pharmaceutical composition or process with claims centered on the active ingredient and formulation.
  • The patent’s claim scope is crucial in assessing potential overlaps with existing patents and freedom to operate.
  • The patent landscape includes prior art in APIs, formulations, and manufacturing methods, influencing patent strength.
  • The regional focus on Brazil requires analyzing local patent laws, including inventive step, novelty, and patentability criteria.
  • Careful claim interpretation and prior art analysis are essential for licensing, enforcement, or design-around strategies.

FAQs

1. How broad are the claims in BRPI0612196?
The claims typically encompass the core composition or method, but their breadth depends on specific wording. Independent claims aim to provide broad coverage, while dependent claims narrow scope.

2. Are there international equivalents of this patent?
The patent may have counterparts within the PCT system or national filings, but actual equivalents should be checked in patent databases like INPI, WIPO PATENTSCOPE, or EPO.

3. What could challenge the validity of BRPI0612196?
Prior art references that predate the filing date, or evidence that the invention is obvious, can challenge validity. This includes earlier patents and scientific publications.

4. How does patent landscape analysis influence business decisions?
It helps identify potential freedom to operate, licensing opportunities, or risk of infringing existing patents, guiding R&D and strategic filings.

5. What are the legal requirements for patentability in Brazil?
The invention must be new, involve an inventive step, and be industrially applicable. Patent applications must also adequately disclose the invention.


References

[1] National Institute of Industrial Property (INPI). (2023). Patent Database. Retrieved from https://npi.inpi.gov.br

[2] WIPO. (2023). PATENTSCOPE Search Service. Retrieved from https://patentscope.wipo.int

[3] European Patent Office. (2023). Espacenet Patent Search. Retrieved from https://worldwide.espacenet.com

[4] United States Patent and Trademark Office. (2023). Patent Full-Text and Image Database. Retrieved from https://patft.uspto.gov

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.